logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Proton Pump Inhibitor class drugs

    FiltersReset Filters
    3 results
    • konvomep

      (omeprazole and sodium bicarbonate)
      Azurity Pharmaceuticals, Inc.
      Usage: KONVOMEP is indicated for the short-term treatment of active benign gastric ulcers in adults (4 to 8 weeks) and for reducing the risk of upper gastrointestinal bleeding in critically ill adult patients.
    • talicia

      (omeprazole magnesium, amoxicillin and rifabutin)
      RedHill Biopharma Ltd
      Usage: TALICIA is indicated for the treatment of Helicobacter pylori infection in adults. It should be used only for infections caused by susceptible bacteria to reduce the development of drug-resistant strains. Therapy selection may consider culture data or local epidemiology when available.
    • vimovo

      (Naproxen and Esomeprazole Magnesium)
      Horizon Therapeutics USA, Inc.
      Usage: VIMOVO, a combination of naproxen and esomeprazole magnesium, is indicated for symptomatic relief of arthritis in adults and adolescents (ages 12+), while helping to reduce the risk of naproxen-associated gastric ulcers. It's not recommended for initial acute pain treatment and is not a substitute for single-ingredient products.